David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Omiganan still in the rosacea pipeline

Omiganan still in the rosacea pipeline

There aren’t many drugs currently in late development for rosacea. Finacea foam and Soolantra have been approved, and it looks like Azultro is on the way. One of the remaining drugs that is still inching its way through the approval process is Omiganan. Confirmation that Omiganan is still alive in the rosacea development pipeline comes from […]

Continue Reading

Elta MD UV Clear Sunscreen SPF46

Elta MD UV Clear Sunscreen SPF46

A reader of Rosacea News sent me an interesting looking tip for a sunscreen that could be a good option for rosacea sufferers. This zinc oxide and octinoxate based sunscreen is available in a tinted and untinted formulation. The sunscreen is promoted as a product that “helps calm and protect sensitive skin types prone to […]

Continue Reading

Rosacea boards fuel rosacea research

Rosacea boards fuel rosacea research

Here are 3 papers that have been written based on what rosacea sufferers have posted over time at the Rosacea Support Community forum site. None of the authors contacted me about their research, rather they sampled the forum postings themselves. So this means that there are some rosacea researchers directly interested in how rosacea sufferers […]

Continue Reading

Soolantra listed at $275 a tube

Soolantra listed at $275 a tube

A recently published paper that seeks to compare the long term, shall we say, `total cost’ of Soolantra, Finacea and Metrogel 0.75%, has given us a window into official listed prices for these prescription items. The following table is from this paper – Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United […]

Continue Reading

Rhofade is gentler than Mirvaso

Rhofade is gentler than Mirvaso

Two small updates on the progress of topical oxymetazoline (now known as Rhofade) towards being available as another treatment for the redness of rosacea. The update tells us firstly that Allergan’s Oxymetazoline based product is in indeed in the final stages of approval, having completed Phase 3 trials and been submitted to the FDA for […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.